Bivalent circular RNA vaccines against porcine epidemic diarrhea virus and transmissible gastroenteritis virus

Bivalent circular RNA vaccines against porcine epidemic diarrhea virus and transmissible gastroenteritis virus

Porcine Epidemic Diarrhea Virus (PEDV) and Transmissible Gastroenteritis Virus (TGEV) pose significant threats to neonatal piglets, leading to severe diarrhea and potentially lethal consequences. Beyond enforcing stringent biosecurity protocols, effective and safe vaccinations are crucial in mitigat...

Full description

Saved in:

Bibliographic Details
Main Authors:	Weibing Zhang, Lei Wang, Liyu Chu, Xu Ma, Wenjing Gao, Yarong Wu, Yongfeng Qiao, Xianjun Wang, Lu Zhao, Hong Hu, Xiaoyu Li, Ding Zhang, Tao Song, Guocan Yu, Haidong Wang, Chunbo Dong, Zhida Liu
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-03-01
Series:	Frontiers in Immunology
Subjects:	circRNA vaccine bivalent porcine epidemic diarrhea virus transmissible gastroenteritis virus sequential vaccination
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2025.1562865/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Development of a novel bivalent vaccine candidate against hepatitis A virus and rotavirus using reverse vaccinology and immunoinformatics
by: Hassan Yarmohammadi, et al.
Published: (2025-03-01)

Study on bivalent attenuated vaccine of infectious bursal disease virus variants
by: ZHOU Ji-yong, et al.
Published: (2000-05-01)

Vaccinia Virus Vector Bivalent Norovirus Vaccine
by: Yunbo Bai, et al.
Published: (2025-02-01)

An attenuated African swine fever virus expressing the E2 glycoprotein of classical swine fever virus protects pigs against challenge of both viruses
by: Jiwen Zhang, et al.
Published: (2025-12-01)

An Mpox Multi-Antigen-Tandem Bivalent mRNA Candidate Vaccine Effectively Protects Mice Against the Vaccinia Virus
by: Jun Zuo, et al.
Published: (2025-03-01)

Humoral and cellular immune response to a single dose of a novel bivalent recombinant adenovirus-vector vaccine against West Nile virus and chikungunya virus in mice
by: Shu Chang, et al.
Published: (2025-07-01)

HUMAN PAPILLOMA VIRUS. NEW OPPORTUNITIES FOR VACCINATION
by: A. G. Gaivoronskaya, et al.
Published: (2014-12-01)

Comparative immunogenicity of monovalent and bivalent adenovirus vaccines carrying spikes of early and late SARS-CoV-2 variants
by: Hengchun Li, et al.
Published: (2024-12-01)

Immunogenicity assessment of Hepatitis A-VP1 and Hepatitis B surface antigen (HBsAg) fusion protein: a novel bivalent vaccine candidate
by: Mina Hannan, et al.
Published: (2025-07-01)

Research Notes: Evaluation of recombinant Newcastle disease virus expressing gB protein of infectious laryngotracheitis virus as bivalent in ovo vaccine
by: Liren Jiang, et al.
Published: (2024-12-01)

XBB.1.5 RBD-Based Bivalent Vaccines Induced Antibody Responses Against SARS-CoV-2 Variants in Mice
by: Jiawen Liu, et al.
Published: (2025-05-01)

Determination of T cell response against XBB variants in adults who received either monovalent wild-type inactivated whole virus or mRNA vaccine or bivalent WT/BA.4-5 COVID-19 mRNA vaccine as the additional booster
by: Yun Sang Tang, et al.
Published: (2024-12-01)

Safety of the bivalent COVID-19 mRNA booster vaccination among persons aged over 18 years in the Republic of Korea
by: Seok-Kyoung Choi, et al.
Published: (2024-12-01)

The indirect effect of the bivalent human papillomavirus vaccination program: an observational cohort study
by: Marit Middeldorp, et al.
Published: (2025-06-01)

Projected health and economic effects of nonavalent versus bivalent human papillomavirus vaccination in preadolescence in the Netherlands
by: Birgit Sollie, et al.
Published: (2025-06-01)

The evolution of vaccine hesitancy through the COVID-19 pandemic: A semi-structured interview study on booster and bivalent doses
by: Jeanna Parsons Leigh, et al.
Published: (2024-12-01)

Perceptions about respiratory syncytial virus (RSV) and attitudes toward the RSV vaccine among the general public in China: A cross-sectional survey
by: Qiang Wang, et al.
Published: (2024-12-01)

Development of an Effective Single-Dose PCV2/CSFV Bivalent Subunit Vaccine Against Classical Swine Fever Virus and Porcine Circovirus Type 2
by: Yu-Chieh Chen, et al.
Published: (2025-07-01)

Efficacy of Inactivated Bivalent SARS-CoV-2 Vaccines Targeting Ancestral Strain (ERAGEM), Delta, and Omicron Variants
by: Busra Kaplan, et al.
Published: (2025-02-01)

The effect of bivalent HPV vaccination against invasive cervical cancer and cervical intraepithelial neoplasia grade 3 (CIN3+) in the Netherlands: a population-based linkage studyResearch in context
by: Marit Middeldorp, et al.
Published: (2025-07-01)

Review of Post-registration Changes in the Life Cycle of Сholera Bivalent Chemical Vaccine (Review)
by: I. V. Shulgina, et al.
Published: (2020-02-01)

The past, present and future of duck plague virus vaccines
by: Linjiang Yang, et al.
Published: (2025-03-01)

An efficient bivalent vaccine against duck Tembusu and duck plague viruses based on ribosomal skipping of DHAV-1 2A1 and abundant expression of DPV protein
by: Liping Wu, et al.
Published: (2025-08-01)

Application of lentinan in suppression of Marek's disease virus infection
by: Qiming Gao, et al.
Published: (2024-12-01)

Construction of Recombinant Marek’s Disease Virus Co-Expressing VP1 and VP2 of Chicken Infectious Anemia Virus
by: Kai Li, et al.
Published: (2024-09-01)

Progress on Respiratory Syncytial Virus Vaccine Development and Evaluation Methods
by: Lie Deng, et al.
Published: (2025-03-01)

A bivalent Mpox nanoparticle vaccine induces robust immune response and provides long-lasting protection against vaccinia virus challenge
by: Yanhai Wang, et al.
Published: (2025-12-01)

Research Progress on Varicella-Zoster Virus Vaccines
by: Hongjing Liu, et al.
Published: (2025-07-01)

Rapid Development of Modified Vaccinia Virus Ankara (MVA)-Based Vaccine Candidates Against Marburg Virus Suitable for Clinical Use in Humans
by: Alina Tscherne, et al.
Published: (2024-11-01)

Insect-specific virus platforms for arbovirus vaccine development
by: Roy A. Hall, et al.
Published: (2025-03-01)

Vaccine Strategies Against RNA Viruses: Current Advances and Future Directions
by: Kuei-Ching Hsiung, et al.
Published: (2024-11-01)

Antigenic variations of recent street rabies virus
by: Wenbo Wang, et al.
Published: (2019-01-01)

Menace of Ebola Virus Disease: A Review
by: Galadima, M.A., et al.
Published: (2021-12-01)

Systemic and Mucosal Antibody Responses to SARS-CoV-2 Variant-Specific Prime-and-Boost and Prime-and-Spike Vaccination: A Comparison of Intramuscular and Intranasal Bivalent Vaccine Administration in a Murine Model
by: Mariam Maltseva, et al.
Published: (2025-03-01)

Recent Progress in the Vaccine Development Against Epstein–Barr Virus
by: Yihao Dai, et al.
Published: (2025-06-01)

Safety, Immunogenicity and Protective Activity of a Modified Trivalent Live Attenuated Influenza Vaccine for Combined Protection Against Seasonal Influenza and COVID-19 in Golden Syrian Hamsters
by: Ekaterina Stepanova, et al.
Published: (2024-11-01)

Recombinant Marek’s disease virus expressing VP1 and VP2 proteins provides robust immune protection against chicken infectious anemia virus
by: Chengfei Ge, et al.
Published: (2025-01-01)

Preexisting yellow fever virus and West Nile virus immunity and pregnancy outcomes in a Nigerian cohort with endemic orthoflavivirus exposure
by: Taewoo Kim, et al.
Published: (2025-12-01)

Exploring monkeypox virus antibody levels: insights from human immunological research
by: Jing Wu, et al.
Published: (2025-05-01)

An inactivated influenza D virus vaccine protects guinea pigs from infections and contact transmission caused by homologous challenge
by: Zhipeng Dong, et al.
Published: (2025-05-01)